FRCPath Haem Part 1 MCQ-Oncology
A 67yr-old pt with intermediate-2 risk Myelofibrosis is treated with JAK Inhibitor. After 8 wks he develops confusion, ataxia, and ophthalmoplegia. Likely cause
Ruxolitinib
Momelotinib
Pacritinib
Fedratinib
top of page
Your success is my success😊
Pass Exam in first Attempt with Hematomorph👇🏼
-Updated and Recorded Videos Bank
-Weekly Online Sessions
(FRCPath Part1 and Part2)
-Online Courses
-Mock Exams
-Detailed Feedbacks
-2500 MCQs and EMQs
-Daily MCQs Practice
-Morphology Sessions
-Beneficial for Transfusion Science and Clinical Science FRCPath
ST3/ST4 Interview Course
Join our WhatsApp community
by sending a message to admin at
+44 7749 871925
Search
bottom of page